Press Releases

06 Jun 2016

EBE and EFPIA Applaud EMA Initiative to Improve Pathway for Advanced Therapy Medicinal Products (ATMPs)

EBE and EFPIA both welcome sincerely the initiative taken by the European Medicines Agency to identify concrete solutions to foster the development of advanced therapy medicinal products, while simultaneously embarking on concerted efforts to expand patient access to them across Europe....

Read more
01 Jun 2016

EBE Annual General Meeting 2016

The EBE Annual Meeting will take place on 14 June 2016 in Brussels from 16h00 to 19h00, at the Radisson Blu Hotel, Rue Fossé-aux-Loups 47 (Room Royale), in close coordination with the EFPIA Statutory General Assembly at the same venue on 15 June. Following the Statutory part of the meeting (from 16-17h) we are proud to offer an opportunity for information and debate to all our members though our session dedicated to IMI – opportunities and challenges for developing Advanced Therapies (from 17h00 to 19h00).  A keynote speech by Pierre Meulien, Executive Director IMI, followed by a moderated panel discussion on the opportunities for EBE members. littlesq register-button2...

Read more
22 Feb 2016

EuropaBio and EBE host a multi-stakeholder debate on the labelling of biosimilar medicines

On 2 February 2016, EuropaBio, the European Association for Bio Industries, and EBE, the European Biopharmaceutical Enterprises, jointly facilitated a multi-stakeholder workshop in Brussels on the labelling of biosimilar medicinal products. 40 people participated in the meeting, including representatives of EU and national associations of patients, physicians and pharmacists. Three representatives from the European Medicines Agency (EMA) attended the meeting as observers.  Update 3 May 2016: Meeting summary available for download  ...

Read more
04 Sep 2015

EBE releases White Paper on Personalised Medicine with a focus on key challenges

EBE today launches its White Paper on Personalised Medicine, which explains the concept and benefits of personalised medicine and sets out key challenges to overcome to make personalised medicine...

Read more
08 Jul 2015

EBE supports making access to personalised medicine a reality for patients – 8 July 2015, Luxembourg

The European Biopharmaceutical Enterprises - EBE - is delighted to participate in the High Level Conference “Making Access to Personalised Medicine a Reality for Patients” organised by the Luxembourg Presidency on 8 July in Luxembourg. ...

Read more
24 Mar 2015

EBE Appoints Barbara Freischem As Its New Executive Director

The board of EBE is delighted to announce the appointment of Barbara Freischem as the new Executive Director. She will take up her post on 29 June 2015. Barbara's responsibilities will include impl...

Read more
11 Dec 2014

European stock market turns towards biotech – BIOCOM report documents upswing/Exchange ranking sees Paris und London in the lead

BIOCOM report documents upswing/Exchange ranking sees Paris und London in the lead Berlin, 25th November 2014. The European capital market has once more become a serious financing alternative. The...

Read more
26 Jun 2014

EU Pharma Sector Challenged as Biopharmaceutical Entrepreneurs Can’t Finance Growth in the EU

(25 June 2014) Brussels. This week the major biopharmaceutical event, BIO, takes place in San Diego (US) attracting many European biopharmaceutical entrepreneurs because they are not able to find sufficient financial support in Europe. According to FlandersBio, a delegation of 75 entrepreneurs from Belgium alone made its way to the US seeking financial support and collaboration partners to help them keep their projects going....

Read more
25 Jun 2014

Industry welcomes translated versions of the European consensus document of biosimilar medicines – (paper is now available in five languages)

After its successful launch in May 2013, the European Consensus Information Paper What you need to know about Biosimilar Medicinal Products is now available in English, French, German, Italian, Spanish and later this summer, Portuguese....

Read more
06 Jun 2014

EBE, European Biopharmaceutical Trade Association, Announces Its Leadership At BioVision, Lyon

(6 June – Lyon, FRANCE): Today the European Biopharmaceutical Enterprises, EBE, is pleased to announce its newly elected Board of Directors for the term 2014-2016. The announcement is being made following the meeting of the EBE Board in the context of the EFPIA Annual Meetings (European Federation of Pharmaceutical Industries and Associations) and the BioVision International Conference in Lyon....

Read more
1 2 3 4